Biotech with a nano-in-micro delivery platform based on calcium phosphate nanoparticles for heart failure.
Founders
Daniele Catalucci(Italy · ♂)— A CNR cardiac researcher, he co-founded NanoPhoria in 2022 as a spin-off to commercialize a calcium-phosphate nano-in-micro delivery platform for a first-in-class heart-failure therapy.
Michele Iafisco(Italy · ♂)— A CNR materials/nanoparticle scientist, he co-founded NanoPhoria in 2022 to develop inorganic calcium-phosphate nanocarriers for delivering therapeutic peptides and RNA.
Alessio Alogna(Italy · ♂)— He co-founded NanoPhoria in 2022, contributing to the CNR spin-off building a tissue-directed lung-to-heart nanoparticle drug-delivery platform.
Claudio De Luca(Italy · ♂)— He co-founded NanoPhoria in 2022 as part of the team commercializing CNR's non-viral nano-in-micro delivery technology for heart failure.
In the network
Shares the most investors with (number = shared investors):